Jerrold Meyer to Neurotoxicity Syndromes
This is a "connection" page, showing publications Jerrold Meyer has written about Neurotoxicity Syndromes.
Connection Strength
1.544
-
Shen EY, Ali SF, Meyer JS. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats. Neuropharmacology. 2011 Dec; 61(8):1183-92.
Score: 0.368
-
Biezonski DK, Meyer JS. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem. 2010 Feb; 112(4):951-62.
Score: 0.329
-
Piper BJ, Farelli JD, Meyer JS. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats. Dev Neurosci. 2009; 31(1-2):90-4.
Score: 0.315
-
Piper BJ, Fraiman JB, Owens CB, Ali SF, Meyer JS. Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology. 2008 Apr; 33(5):1192-205.
Score: 0.279
-
Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. J Pharmacol Exp Ther. 2006 May; 317(2):838-49.
Score: 0.252